Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto 0, 1, 2, ...13, 14, Next
Reported
DateTime		TypeCompany
Symbol		Filed By
Symbol		Shares Owned
% Owned		Shares Vs. Prev ReportFiling
2023-05-24
4:52 pm
Sale		13DVectivBio Holding AG
VECT		ORBIMED ADVISORS LLC5,156,561
7.7%		-1,557,000decrease
(-23.19%)		View
2023-05-24
4:47 pm
Purchase		13DPrelude Therapeutics Incorporated
PRLD		ORBIMED ADVISORS LLC15,716,642
28.6%		869,565increase
(+5.86%)		View
2023-05-17
4:46 pm
Sale		13DSpringWorks Therapeutics, Inc.
SWTX		ORBIMED ADVISORS LLC4,178,588
6.7%		-806,412decrease
(-16.18%)		View
2023-05-16
4:28 pm
Unchanged		13DFusion Pharmaceuticals Inc.
FUSN		ORBIMED ADVISORS LLC2,930,670
4.6%		0
(Unchanged)		View
2023-05-16
4:25 pm
Sale		13DVerona Pharma plc
VRNA		ORBIMED ADVISORS LLC3,777,778
4.8%		-482,913decrease
(-11.33%)		View
2023-05-08
5:01 pm
Purchase		13DKinnate Biopharma Inc.
KNTE		ORBIMED ADVISORS LLC7,559,729
16.2%		1,460,932increase
(+23.95%)		View
2023-05-05
11:14 am
Unchanged		13DXtant Medical Holdings, Inc.
XTNT		ORBIMED ADVISORS LLC73,114,592
67.1%		0
(Unchanged)		View
2023-05-02
7:28 pm
Purchase		13DKinnate Biopharma Inc.
KNTE		ORBIMED ADVISORS LLC6,098,797
13.1%		1,405,168increase
(+29.94%)		View
2023-04-21
5:03 pm
Sale		13DTELA Bio, Inc.
TELA		ORBIMED ADVISORS LLC2,866,267
11.9%		-192,000decrease
(-6.28%)		View
2023-04-11
7:10 pm
Purchase		13DApollomics Inc.ORBIMED ADVISORS LLC662,561
10.3%		662,561increase
(New Position)		View
2023-04-07
4:38 pm
Sale		13DGalecto, Inc.
GLTO		ORBIMED ADVISORS LLC2,696,654
10.5%		-74,790decrease
(-2.70%)		View
2023-03-31
4:48 pm
Purchase		13DGracell Biotechnologies Inc.
GRCL		ORBIMED ADVISORS LLC7,583,576
11.2%		1,612,904increase
(+27.01%)		View
2023-03-29
5:24 pm
Unchanged		13DTerns Pharmaceuticals, Inc.
TERN		ORBIMED ADVISORS LLC7,619,135
13.4%		0
(Unchanged)		View
2023-03-24
4:57 pm
Unchanged		13DCalciMedica Inc.
GRAY		ORBIMED ADVISORS LLC297,380
5.4%		0
(Unchanged)		View
2023-03-24
4:43 pm
Sale		13D89bio, Inc.
ETNB		ORBIMED ADVISORS LLC0
0%		-1,504,436decrease
(Position Closed)		View
2023-03-22
4:27 pm
Sale		13DCalciMedica IncORBIMED ADVISORS LLC297,380
18.9%		-3,865,967decrease
(-92.86%)		View
2023-03-14
4:19 pm
Purchase		13DTheseus Pharmaceuticals, Inc.
THRX		ORBIMED ADVISORS LLC17,233,668
39.6%		395,000increase
(+2.35%)		View
2023-02-28
5:09 pm
Sale		13DFusion Pharmaceuticals Inc.
FUSN		ORBIMED ADVISORS LLC2,930,670
4.7%		-67,311decrease
(-2.25%)		View
2023-02-28
4:00 pm
Purchase		13DEnliven Therapeutics Inc.
IMRA		ORBIMED ADVISORS LLC8,949,339
21.8%		8,949,339increase
(New Position)		View
2023-02-23
3:23 pm
Purchase		13DKinnate Biopharma Inc.
KNTE		ORBIMED ADVISORS LLC4,693,629
10.6%		1,295,700increase
(+38.13%)		View
Goto 0, 1, 2, ...13, 14, Next